Epitero 50 mg Injection 1's is utilized for the treatment of breast cancer. The specific applications of Epitero 50 mg Injection 1's include:<br/>• Assists in managing breast cancer post-surgery: Epitero 50 mg Injection 1's is administered alongside other medications to address breast cancer in individuals who have undergone surgical removal of the tumor.<br/>• Aids in controlling the spread of cancer: Epitero 50 mg Injection 1's functions to inhibit or halt the proliferation of any remaining cancer cells in the body.<br/>
Sale!
![]()
EPITERO INJECTION 50MG
Epirubicin Hydrochloride for Injection 50mg
| MRP | : |
|
| Price | : | ₹1,050.00 |
| You Save | : | ₹121.42 (10.37%) |
1 Vial 1 Injection
Epitero 50 mg Injection 1’s is an anti-cancer medication utilized alongside other treatments to address breast cancer in individuals who have undergone tumor removal surgery.
This injection serves as adjuvant chemotherapy for women with axillary lymph nodes affected by breast cancer (characterized by abnormal cell growth in the breast).
Containing Epirubicin, Epitero 50 mg Injection 1’s falls under the category of anthracycline topoisomerase inhibitors. It works by inhibiting the topoisomerase II enzyme through the intercalation of DNA base pairs, leading to the uncoiling of double helix DNA, which ultimately disrupts DNA and RNA synthesis.
Potential side effects of Epitero 50 mg Injection 1’s include nausea, headaches, abdominal discomfort, decreased appetite, vomiting, dizziness, mouth sores, fatigue, back pain, diarrhea, and pain at the injection site. Most of these effects are mild and typically resolve without medical intervention over time. However, if they persist, it is advisable to consult your healthcare provider. Administration of Epitero 50 mg Injection 1’s should be performed by a qualified healthcare professional; self-administration is not recommended. Your physician will determine the appropriate dosage based on your health status.
Individuals with known allergies to Epitero 50 mg Injection 1’s should avoid its use. It is contraindicated for patients with a recent history of myocardial infarction (MI) or heart attack, those with a baseline neutrophil count below 1500 cells/mm3, severe arrhythmias, prior treatment with anthracyclines, and significant liver dysfunction. Therefore, it is crucial to refrain from using this medication under these circumstances. Notify your doctor if you have any cardiovascular issues, liver or kidney diseases, or if you are taking other medications such as cardiotoxic drugs (e.g., Thalidomide, doxorubicin, Abiraterone, tamoxifen, letrozole) and cimetidine, as these can lead to serious adverse effects. Additionally, Epitero 50 mg Injection 1’s is associated with embryo-fetal toxicity, making it contraindicated for pregnant or breastfeeding women. It is also not recommended for pediatric patients as it is not suitable for children.
